Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Wall Street Rallies Dow Achieves Record High Amid Optimism Over Middle East Situation China Confirms Order for 200 Boeing Aircraft Signals Aviation as Key Cooperation Area with US Phillies Former Pitcher Released by NL Contender After Brief ThreeGame Stint Payroll Implications for Contending Teams US Real GDP Growth 19902025 Three Decades of Expansion Crisis and Recalibration SPIC Reports Higher Q4 Profit on Improved Cost Management FullYear Net Income Rises Michael Saylor Predicts Tokenization Will Let Investors Shop for Yield Challenging Traditional Finance Arch Capital Group Q1 2026 Earnings EPS Misses Consensus by a Small Margin Shares Edge Higher Euronet Worldwide EEFT Q1 2026 Earnings EPS Beat Drives Nuanced Outlook Amid Broader Market Headwinds ONBPP Q1 2026 Earnings Slight EPS Miss Flat Stock Reaction for Old National Bancorp Preferred HCWC Q4 2025 Earnings Narrow EPS Beat Masks Operational Uncertainty Shares Slip AMCX Q1 2026 Earnings Profitability Falls Short as CordCutting Pressures Persist EIC Q4 2025 Earnings Narrow EPS Miss Amid Steady Performance Halozyme Therapeutics HALO Rises Modestly Support and Resistance Levels in Focus Rayonier Advanced Materials RYAM Gains 213 as Shares Test Key Resistance Afya Limited AFYA Edges Higher as Stock Holds Above Key Support Level loanDepot Inc LDI Edges Higher as Stock Holds Above Key Support Level SiTime SITM Shares Dip 2 as ProfitTaking Follows Recent Rally Support at 691 Sysco Corporation SYY Q1 2026 Earnings Slight EPS Miss Amid Steady Operational Performance Fractyl Health Q1 2026 Earnings Narrowerthanexpected loss fails to lift stock as pipeline progress awaited CEVA Inc Q1 2026 Earnings Strong EPS Beat Lifts Shares NextDecade Corporation Q1 2026 Earnings EPS Surprise Beats Estimates Amid PreRevenue Phase RDZN Q1 2026 Earnings Significant EPS Miss Amidst Transition SILO Q4 2023 Earnings EPS Misses Estimates as Biotech Firm Reports Wider Than Expected Loss